Omvoh achieves steroid-free disease control at one year in ulcerative colitis and Crohn’s disease – Eli Lilly
New data analyses from Eli Lilly and Company show patients with moderately to severely active ulcerative colitis (UC) and Crohn’s disease treated with Omvoh (mirikizumab-mrkz) achieved multiple treatment… read more.




